Skip to content

Clinical trials

Pulmonary Embolism trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20074
20091
20142
20171
20191
20222
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Anthos Therapeutics, Inc.2
Bristol-Myers Squibb2
Daiichi Sankyo2
Regeneron Pharmaceuticals1
Samsung Medical Center1
Yonsei University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism13
Venous Thrombosis12
Venous Thromboembolism8
Thromboembolism3
Thrombosis3
Cardiovascular Diseases1
Embolism and Thrombosis1
Gastrointestinal Neoplasms1
Neoplasms1
Vascular Diseases1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.